(Supplementary Indent) (2025-26) Adalimumab Inj 40Mg Per 0.8Ml Tender, Delhi (NCT) - 124893976

NORTHERN RAILWAY has floated a tender for (Supplementary Indent) (2025-26) Adalimumab Inj 40Mg Per 0.8Ml. The project location is New Delhi, Delhi (NCT), India. The reference number is - and it is closing on 25 Aug 2025. Suppliers can request Register free of cost to get the complete Tender details and download the document.

Procurement Summary

State: Delhi (NCT)

Summary: (Supplementary Indent) (2025-26) Adalimumab Inj 40Mg Per 0.8Ml

Deadline: 25 Aug 2025

Other Information

Notice Type: Tender

TOT Ref.No.: 124893976

Document Ref. No.: Login to see detail

Financier: Self Financed

Purchaser Ownership: Public

Document Fees: Refer Document

Tender Value: Refer Document

EMD: Refer Document

Purchaser's Detail

Name: Login to see details

Address: Login to see details

Email: Login to see details

  Login to see details

Documents

 Tender Notice

viewNitPdf_5087113.pdf

5248352.pdf


Emudhra